glp-1 market share Size, Scope, Forecast Report 2026 to 2035 GLP-1 Agonists Weight Loss Drugs

Patients often seek it as part of an anti-aging approach to maintain a youthful appearance

The thinking applied to my starting to trial a GLP-1 medication to see if it helped move the needle on my reactivity and pain

NMN and NR serve as precursors to NAD+, with NMN positioned one step closer in the biosynthesis pathway

Pre-treatment: Measure morning resting heart rate for 5 days Calculate average baseline Record any existing caffeine or stimulant use During treatment: Measure resting heart rate 3 times weekly during dose escalation Continue at each dose for minimum 4 weeks before increasing If resting HR exceeds baseline by more than 15 BPM, hold dose for an additional 2 weeks If resting HR exceeds 100 BPM at rest on two or more measurements, consult physician Expected timeline: Weeks 1-8: minimal heart rate change at starting doses Weeks 8-24: gradual increase of 5-10 BPM at therapeutic doses Weeks 24+: stabilization and gradual decline toward baseline This is the approach most researchers follow successfully, and it aligns with the standard retatrutide dosing protocol used in clinical trials